Should You Buy Microsoft Stock After Its Correction, or Run for the Hills?

Microsoft reported fiscal Q2 revenue of $81.3 billion, up 17% year over year, with adjusted EPS of $4.14, up 24%, and Azure revenue growth accelerating 39%. The article argues the stock has fallen more than 20% year to date and trades at 20x forward fiscal 2027 EPS, but highlights a $625 billion commercial RPO backlog, including $250 billion in OpenAI commitments, as support for future growth. Overall, this is a valuation and sentiment discussion rather than new company-specific catalyst news.

Analysis

MSFT is being priced less like a compounder and more like a two-sided option on AI adoption: if enterprise AI spend proves durable, Azure and the broader productivity stack still monetize the workflow layer; if not, the market will punish it for being the most visible buyer of AI capex with the least obvious near-term ROIC proof. That setup creates a classic multiple compression asymmetry: the underlying earnings can keep compounding while the stock lags until management can show conversion from commitments to durable margin expansion.

The bigger second-order issue is competitive positioning, not headline growth. Alphabet and Amazon own the “infrastructure efficiency” narrative because custom silicon lowers unit economics and gives them more pricing flexibility; Microsoft’s relative chip disadvantage means it may need to subsidize demand longer or accept lower cloud margins to defend share. Over 6-12 months, that can keep Azure growth strong while still capping forward multiples, especially if investors begin comparing incremental spend efficiency rather than top-line growth alone.

The market is also underestimating inertia in the productivity layer. Even if copilots face feature competition, Microsoft’s embedded security, identity, and compliance stack makes displacement a multi-year process, so the bear case is more about slowed upsell velocity than outright churn. That suggests the current drawdown is likely overdone on a 3-6 month horizon if enterprise IT budgets remain intact, but not necessarily a clean “buy the dip” unless there is evidence that AI attach rates are converting into operating leverage rather than just keeping growth elevated.

The contrarian setup is that the best near-term risk/reward may not be a standalone long MSFT but a relative-value expression versus the lower-cost infrastructure leaders. If the AI buildout remains rational, capex-heavy hyperscalers with better silicon economics should outperform; if AI monetization disappoints, all three names de-rate, but MSFT’s valuation support from recurring software cash flows should make it the least fragile of the mega-cap trio.

Key Decisions for Investors

• Pair trade: long AMZN / short MSFT for 3-6 months — thesis is better capex efficiency and custom silicon economics; stop if MSFT shows clear operating margin expansion from AI attach or if Azure re-accelerates on better-than-expected monetization.
• Relative-value long GOOGL vs MSFT on a 6-12 month horizon — same AI demand pool, but stronger control over inference costs and better optionality from custom chips; risk is that Microsoft converts its installed base into a faster copilots monetization cycle.
• Tactical long MSFT only on further weakness into the next earnings print, sized for a 2-4 quarter mean reversion — upside is a rerating if management proves RPO converts into revenue with stable margins; downside is another multiple reset if capex commentary stays aggressive.
• Avoid shorting NVDA here; use it as a hedge leg only if you want to express skepticism about AI spend ROI — if enterprise demand is merely delayed rather than broken, NVDA can keep outperforming even when software multiples compress.
• If owning MSFT outright, hedge with a short-dated call spread against the next catalyst window — keeps upside if the stock re-rates on guidance, while reducing exposure to another sentiment-driven de-rating.